XML 39 R22.htm IDEA: XBRL DOCUMENT v3.10.0.1
EQUITY
12 Months Ended
Dec. 31, 2018
EQUITY  
EQUITY

11. EQUITY

Common Stock

The Company has paid quarterly dividends on its common stock since January 1999.

Treasury Stock

In September 2004, the Company’s Board of Directors approved a $5.0 million stock buyback plan (the “2004 Repurchase Plan”).  Through September 19, 2016, the Company repurchased $4.1 million of its common stock, under the 2004 Repurchase Plan.

 

On September 19, 2016, the Company’s Board of Directors authorized the repurchase of up to $50.0 million of its common stock, from time to time, on the open market or in privately negotiated transactions (the “2016 Repurchase Plan”).  The 2016 Repurchase Plan replaces the 2004 Repurchase Plan.  As of December 31, 2018, the Company has $37.7 million available to be repurchased under the 2016 Repurchase Plan.

 

During the years ended December 31, 2018, 2017 and 2016, the Company repurchased the following shares under the 2004 Repurchase Plan and the 2016 Repurchase Plan:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Aggregate

 

 

 

 

 

 

Shares

 

Cost

 

Average

 

Year ended December 31, 

    

Repurchased

    

(in thousands)

    

Repurchase Price

 

2018

 

30,427

 

$

1,577

 

$

51.82

 

2017

 

201,932

 

 

10,636

 

 

52.67

 

2016

 

32,407

 

 

2,195

 

 

64.72

 

 

During the years ended December 31, 2018, 2017 and 2016, the Company repurchased the following shares from employees to satisfy tax withholding and stock options exercise obligations incurred in connection with the vesting of restricted stock awards and the exercise of stock options:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Aggregate

 

 

 

 

 

 

Shares

 

Cost

 

Average

 

Year ended December 31, 

    

Repurchased

    

(in thousands)

    

Repurchase Price

 

2018

 

141,180

 

$

10,859

 

$

76.76

 

2017

 

32,814

 

 

2,348

 

 

71.54

 

2016

 

38,279

 

 

2,775

 

 

72.50

 

 

Stock‑Based Compensation

The Company reserved 2,000,000 shares for the grant of stock options, restricted stock awards, restricted stock units, stock equivalents and awards of shares of common stock that are not subject to restrictions or forfeiture.  As of December 31, 2018, the Company has approximately 801,000 shares available for grants.

Stock Options

Stock options have a term of ten years and vest annually and ratably over a period of four years.

The following table summarizes stock option activity for the years ended December 31, 2018 and 2017:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31, 2018

 

 

 

 

 

 

 

 

Weighted Average

 

 

 

 

 

 

 

 

Weighted Avg.

 

Remaining

 

 

 

 

 

 

Number of

 

Exercise

 

Contractual

 

Aggregate

 

 

    

Options

    

Price

    

Term (Years)

    

Intrinsic Value

 

Outstanding at January 1, 2018

 

200,021

 

$

41.76

 

 

 

 

 

 

Granted

 

 —

 

 

 —

 

 

 

 

 

 

Exercised

 

(158,021)

 

 

39.95

 

 

 

 

 

 

Outstanding at December 31, 2018

 

42,000

 

 

48.61

 

4.1

 

$

823,515

 

Vested and expected to vest at December 31, 2018

 

42,000

 

 

48.61

 

4.1

 

$

962,840

 

Exercisable at December 31, 2018

 

33,250

 

 

46.76

 

3.0

 

$

823,515

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31, 2017

 

 

 

 

 

 

 

 

Weighted Average

 

 

 

 

 

 

 

 

 

 

 

Remaining

 

 

 

 

 

 

Number of

 

Weighted Avg.

 

Contractual

 

Aggregate

 

 

    

Options

    

Exercise Price

    

Term (Years)

    

Intrinsic Value

 

Outstanding at January 1, 2017

 

225,822

 

$

39.77

 

 

 

 

 

 

Granted

 

10,000

 

 

52.97

 

 

 

 

 

 

Exercised

 

(35,801)

 

 

32.29

 

 

 

 

 

 

Outstanding at December 31, 2017

 

200,021

 

 

41.76

 

3.6

 

$

2,780,253

 

Vested and expected to vest at December 31, 2017

 

200,021

 

 

41.76

 

3.6

 

$

2,780,253

 

Exercisable at December 31, 2017

 

187,521

 

 

40.77

 

3.6

 

$

2,757,353

 

 

The unvested options as of December 31, 2018 represent $0.1 million in unamortized stock‑based compensation which will be recognized over a weighted average term of 2.3 years.

The following table summarizes information relating to options granted and exercised during the years ended December 31, 2018, 2017 and 2016 (in thousands, except fair value of options granted data):

 

 

 

 

 

 

 

 

 

 

 

 

    

2018

    

2017

    

2016

 

Weighted-average fair value of options granted

 

$

 —

 

$

13.77

 

$

 —

 

Aggregate intrinsic value of options exercised

 

 

5,927

 

 

936

 

 

1,591

 

Cash proceeds received upon exercise of options

 

 

72

 

 

1,030

 

 

649

 

Excess tax benefits from share-based compensation

 

 

 —

 

 

 —

 

 

591

 

The aggregate intrinsic value represents the total pre‑tax intrinsic value (the difference between the Company’s closing common stock price on December 31st and the exercise price, multiplied by the number of the in‑the‑money stock options) that would have been received by the stock option holders had all stock options holders exercised their stock options on December 31st. The amount of aggregate intrinsic value will change based on the fair market value of the Company’s common stock.

The estimated fair value of the options granted during the year ended December 31, 2017 was determined using a Black Scholes option pricing model, based on the following weighted average assumptions:

 

 

 

 

2017

 

 

 

 

Risk-free interest rate

1.79

%  

Expected dividend yield

1.28

%  

Expected life

4.00

years

Expected volatility

34.01

%  

 

The Company did not grant any options during the years ended December 31, 2018 or 2016.  The Company recognized $0.1 million, $0.1 million and $0.1 million, respectively, of stock compensation expense relating to the granted options during 2018, 2017, and 2016, respectively.

 

Restricted Stock

Restricted stock issued under the 2008 Equity Investment Plan vest ratably over four years.

The following table summarizes restricted stock activity during the year ended December 31, 2018:

 

 

 

 

 

 

 

 

    

 

 

Weighted Avg.

 

 

    

Shares

    

Fair Value

 

Unvested as of January 1, 2018

 

214,938

 

$

68.62

 

Granted

 

111,474

 

 

59.52

 

Forfeited

 

(31,327)

 

 

66.53

 

Vested and issued

 

(94,432)

 

 

66.27

 

Unvested as of December 31, 2018

 

200,653

 

$

65.21

 

 

The following table summarizes restricted stock activity during the year ended December 31, 2017:

 

 

 

 

 

 

 

 

    

 

 

Weighted Avg. 

 

 

    

Shares

    

Fair Value

 

Unvested as of January 1, 2017

 

229,040

 

$

67.13

 

Granted

 

95,095

 

 

68.09

 

Forfeited

 

(12,074)

 

 

69.71

 

Vested and issued

 

(97,123)

 

 

64.01

 

Unvested as of December 31, 2017

 

214,938

 

$

68.62

 

 

In connection with the grant of restricted shares, the Company recognized $6.1 million, $6.6 million and $6.2 million of compensation expense within its income statements for the years ended December 31, 2018, 2017, and 2016, respectively.  In addition, the Company recognized $0.2 million, $0.3 million, and $0.1 million of compensation expense within its income statement for the year ended December 31, 2018, 2017 and 2016, respectively, for shares of the Company’s subsidiaries granted to the management team of those subsidiaries.

The unvested shares as of December 31, 2018 represent $9.0 million in unamortized stock based compensation which will be recognized over a weighted average period of 2.5 years.